Task: Type IB Variation
HL7 FHIR R5 – APIX Implementation Guide
Task Description
Validation of Type IB Variation
Core Task Information
Version ID2Task IDtask-workflow-step2Instance UUIDurn:uuid:workflow-step1-instanceGroup Identifierurn:uuid:workflow-group-id-12345Procedure IDEMEA/H/C/001234/IB/0025Task StatusacceptedBusiness StatusValidation SuccessfulIntentorderPriorityroutine
CodeType IB Variation (variation-type-ib)Authored2025-11-15 09:00:00 UTC+01:00Last Updated2025-11-20 14:30:00 UTC+01:00
Parties Involved
RequesterSynthPharma AG
Address: 123 Synthetic Research Blvd, 4000 Basel, Switzerland
Contact: Dr. John Doe, Head of Regulatory Affairs
Email: john.doe@synthpharma.example
PerformerEuropean Medicines Agency – Human Medicines Evaluation Division
Address: Domenico Scarlattilaan 6, 1083 HS Amsterdam, Netherlands
Contact: Scientific and Regulatory Management
Email: srm@ema.example.eu
Input Documents10 documents
Module 1
Cover Letter
cover-letterCover Letter.pdf
Application Form
application-formApplication Form.pdf
Annotated Label
annotated-labelAnnotated Label.pdf
Clean Label
clean-labelClean Label.pdf
Pack Mockup
pack-mockupPack Mockup.pdf
Module 3
Stability Summary
cmc-stability-summaryCMC Doc 1 - Summary.pdf
Stability Data
cmc-stability-dataCMC Doc 2 - Data.pdf
Stability Commitment
cmc-stability-commitmentCMC Doc 3 - Commitment.pdf
DS Stability Summary
cmc-ds-stability-summaryCMC Doc 4 - DS Summary.pdf
DS Stability Data
cmc-ds-stability-dataCMC Doc 5 - DS Data.pdf
Output Documents2 documents
Regulator Output
Acknowledgement of Receipt
acknowledgement-receiptAcknowledgement_Letter.pdf
Validation Report
validation-reportValidation_Report.pdf
HL7 FHIR R5 – API Exchange for Medicinal Products (APIX)
Generated Render